---
title: "TCGX Asia Life Sciences Fund I, L.P. SEC filings"
url: https://altstreet.investments/edgar/2140843
kind: edgar-entity
updated: 2026-08-05
publisher: AltStreet (https://altstreet.investments)
license: Public factual pages may be read, quoted and cited with attribution and a link. Bulk redistribution is not permitted.
---

# TCGX Asia Life Sciences Fund I, L.P.: SEC filings and what they report

TCGX Asia Life Sciences Fund I, L.P. is a Cayman Islands-domiciled pooled investment fund filing under Rule 506(b) and Section 3(c). This is a pre-open filing with no disclosed capital raised, investor count, or minimum investment. Director Chen Yu is listed as the related person.

| Field | Value |
| --- | --- |
| Entity | TCGX Asia Life Sciences Fund I, L.P. |
| CIK | 2140843 |
| Filing family | 506(b), 3(c) |
| Entity type | fund vehicle |
| Manager (as filed) | TCGX |
| Newest fact-bearing filing | July 29, 2026, accession 0002140843-26-000001 |
| Total offering amount (as filed) | $600,000,000 |
| Total sold (as reported) | $0 |
| Investors (as reported) | 70 |
| Vintage | 2026 |

## Related persons (Form D Item 3)

| Name | Relationship |
| --- | --- |
| CHEN YU | Director |


## Filings (2 on record, newest first)

| Date | Form | Family | SEC link |
| --- | --- | --- | --- |
| October 7, 2026 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/2140843/000214084326000003/ |
| July 29, 2026 | D | Form D | https://www.sec.gov/Archives/edgar/data/2140843/000214084326000001/ |


## More

- Entity page (HTML, with events, parties and the platform record): https://altstreet.investments/edgar/2140843
- SEC EDGAR filing index: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002140843&owner=include&count=40
- Signal history, evidence passages and the entity graph are AltStreet Terminal features: https://altstreet.investments/terminal

---

Source page: https://altstreet.investments/edgar/2140843
Machine index: https://altstreet.investments/llms.txt
AltStreet reads what platforms, funds and issuers file with the SEC and what they tell investors, and publishes the difference. Figures are as filed or as captured on the date stated; nothing here is investment advice.